Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Antimalarial drug discovery: targeting protein kinases.

Doerig C, Meijer L.

Expert Opin Ther Targets. 2007 Mar;11(3):279-90. Review.

PMID:
17298288
2.

Drugging the Plasmodium kinome: the benefits of academia-industry synergy.

Leroy D, Doerig C.

Trends Pharmacol Sci. 2008 May;29(5):241-9. doi: 10.1016/j.tips.2008.02.005. Epub 2008 Apr 18. Review.

PMID:
18394721
3.

Plasmodium kinases as targets for new-generation antimalarials.

Lucet IS, Tobin A, Drewry D, Wilks AF, Doerig C.

Future Med Chem. 2012 Dec;4(18):2295-310. doi: 10.4155/fmc.12.183. Review.

PMID:
23234552
4.

Malaria: targeting parasite and host cell kinomes.

Doerig C, Abdi A, Bland N, Eschenlauer S, Dorin-Semblat D, Fennell C, Halbert J, Holland Z, Nivez MP, Semblat JP, Sicard A, Reininger L.

Biochim Biophys Acta. 2010 Mar;1804(3):604-12. doi: 10.1016/j.bbapap.2009.10.009. Epub 2009 Oct 17. Review.

PMID:
19840874
5.

Exploring novel targets for antimalarial drug discovery: plasmodial protein kinases.

Jirage D, Keenan SM, Waters NC.

Infect Disord Drug Targets. 2010 Jun;10(3):134-46. Review.

PMID:
20334624
6.

Targeting protein kinases in the malaria parasite: update of an antimalarial drug target.

Zhang VM, Chavchich M, Waters NC.

Curr Top Med Chem. 2012;12(5):456-72. Review.

PMID:
22242850
7.

Novel molecular targets for antimalarial chemotherapy.

Jana S, Paliwal J.

Int J Antimicrob Agents. 2007 Jul;30(1):4-10. Epub 2007 Mar 6. Review.

PMID:
17339102
8.

Plasmodium falciparum: new molecular targets with potential for antimalarial drug development.

Gardiner DL, Skinner-Adams TS, Brown CL, Andrews KT, Stack CM, McCarthy JS, Dalton JP, Trenholme KR.

Expert Rev Anti Infect Ther. 2009 Nov;7(9):1087-98. doi: 10.1586/eri.09.93. Review.

PMID:
19883329
9.

Helicases - feasible antimalarial drug target for Plasmodium falciparum.

Tuteja R.

FEBS J. 2007 Sep;274(18):4699-704. Review.

10.

Falcipains, Plasmodium falciparum cysteine proteases as key drug targets against malaria.

Teixeira C, Gomes JR, Gomes P.

Curr Med Chem. 2011;18(10):1555-72. Review.

PMID:
21428877
11.
12.

Plasmodium falciparum pyruvate kinase as a novel target for antimalarial drug-screening.

Chan M, Tan DS, Sim TS.

Travel Med Infect Dis. 2007 Mar;5(2):125-31. Epub 2006 May 15.

PMID:
17298920
13.

Protein-drug interaction studies for development of drugs against Plasmodium falciparum.

de Azevedo WF Jr, Caceres RA, Pauli I, Timmers LF, Barcellos GB, Rocha KB, Soares MB.

Curr Drug Targets. 2009 Mar;10(3):271-8. Review.

PMID:
19275563
14.

Unraveling the 'DEAD-box' helicases of Plasmodium falciparum.

Tuteja R, Pradhan A.

Gene. 2006 Jul 5;376(1):1-12. Epub 2006 Apr 7. Review.

PMID:
16713133
15.

The impact of antimalarial drug resistance mutations on parasite fitness, and its implications for the evolution of resistance.

Hastings IM, Donnelly MJ.

Drug Resist Updat. 2005 Feb-Apr;8(1-2):43-50. Epub 2005 Apr 18. Review.

PMID:
15939341
16.

Paradigm shifts in malaria parasite biochemistry and anti-malarial chemotherapy.

Surolia N, RamachandraRao SP, Surolia A.

Bioessays. 2002 Feb;24(2):192-6.

PMID:
11835284
17.

Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.

Na-Bangchang K, Karbwang J.

Fundam Clin Pharmacol. 2009 Aug;23(4):387-409. doi: 10.1111/j.1472-8206.2009.00709.x. Review.

PMID:
19709319
18.

Novel molecular targets for antimalarial drug development.

Sahu NK, Sahu S, Kohli DV.

Chem Biol Drug Des. 2008 Apr;71(4):287-97. doi: 10.1111/j.1747-0285.2008.00640.x. Epub 2008 Feb 22. Review.

PMID:
18298458
19.

Novel approaches to antimalarial drug discovery.

Biot C, Chibale K.

Infect Disord Drug Targets. 2006 Jun;6(2):173-204. Review.

PMID:
16789878
20.

The alpha-carbonic anhydrase from the malaria parasite and its inhibition.

Krungkrai J, Supuran CT.

Curr Pharm Des. 2008;14(7):631-40. Review.

PMID:
18336308

Supplemental Content

Support Center